Pharmaceutical supplier Ebos Group has announced the retirement of chairman Mark Maller, who played a pivotal role in the business’ growth over his 27 year tenure.
Waller will stay on until the conclusion of its upcoming AGM, when he will be succeeded by current independent director Elizabeth Coutts.
Ebos Group owns Terry White Chemmart, Ebos Healthcare, Symbion, ProPharma, Animates, and Black Hawk pet care, among others.
After joining the business in 1984 as chief financial officer, Waller went on to become chief executive in 1987 and led an ambitious growth strategy, which took Ebos from annual revenues of approximately $8 million, to over $6 billion.
Waller stepped down as chief executive in 2014, and assumed the role of chairman in 2015.
“During his career Mr Waller has received many business accolades including the Chief Executive of the Year Award at the Deloitte 200 Awards in 2011 and the Leadership Award at the INFINZ Industry Awards in 2014,” Ebos Group general counsel Janelle Cain wrote.
“In August 2019, he received the ultimate recognition of his significant contribution to the New Zealand business with his induction into the New Zealand Business Hall of Fame.”
Replacing Waller as of October 15, Elizabeth Coutts has been a director of Ebos Group since 2003, and formerly served as the chairman of Meritec Group, Industrial Research and LIfe Pharmacy Limited.
The group will report its full year earnings on 22 August, though enjoyed a 4 per cent boost in net profit after tax to $75.8 million in the first half largely driven by its animal care segment.
At the time, Ebos Group said it expected to generate earnings growth across the remainder of the year and into FY20 as it reaps the benefits of its contract to supply Chemist Warehouse.
